141 related articles for article (PubMed ID: 26520652)
1. Surgical and oncological impact of main pancreatic duct spread in invasive ductal adenocarcinoma: A clinicopathological study of 184 resected cases.
Ishii M; Kimura Y; Sugita S; Imamura M; Ito T; Nobuoka T; Meguro M; Hasegawa T; Mizuguchi T; Hirata K
Pancreatology; 2015; 15(6):681-7. PubMed ID: 26520652
[TBL] [Abstract][Full Text] [Related]
2. The distance of tumor spread in the main pancreatic duct of an intraductal papillary-mucinous neoplasm: where to resect and how to predict it.
Okada K; Imaizumi T; Hirabayashi K; Matsuyama M; Yazawa N; Dowaki S; Tobita K; Ohtani Y; Kawaguchi Y; Tanaka M; Inokuchi S; Makuuchi H
J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):516-22. PubMed ID: 20714841
[TBL] [Abstract][Full Text] [Related]
3. Comparison of patients with invasive intraductal papillary mucinous carcinoma and invasive ductal carcinoma of the pancreas: a pathological type- and stage-matched analysis.
Izumo W; Higuchi R; Furukawa T; Yazawa T; Uemura S; Matsunaga Y; Shiihara M; Yamamoto M
Scand J Gastroenterol; 2019 Nov; 54(11):1412-1418. PubMed ID: 31680568
[No Abstract] [Full Text] [Related]
4. Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: when can we operate or observe?
Jang JY; Kim SW; Lee SE; Yang SH; Lee KU; Lee YJ; Kim SC; Han DJ; Choi DW; Choi SH; Heo JS; Cho BH; Yu HC; Yoon DS; Lee WJ; Lee HE; Kang GH; Lee JM
Ann Surg Oncol; 2008 Jan; 15(1):199-205. PubMed ID: 17909912
[TBL] [Abstract][Full Text] [Related]
5. Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakashima A; Sueda T
J Surg Oncol; 2009 Jul; 100(1):13-8. PubMed ID: 19384908
[TBL] [Abstract][Full Text] [Related]
6. R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use.
Rau BM; Moritz K; Schuschan S; Alsfasser G; Prall F; Klar E
Surgery; 2012 Sep; 152(3 Suppl 1):S103-11. PubMed ID: 22766366
[TBL] [Abstract][Full Text] [Related]
7. Role of intraoperative cytology combined with histology in detecting continuous and skip type intraductal cancer existence for intraductal papillary mucinous carcinoma of the pancreas.
Eguchi H; Ishikawa O; Ohigashi H; Sasaki Y; Yamada T; Nakaizumi A; Uehara H; Takenaka A; Kasugai T; Imaoka S
Cancer; 2006 Dec; 107(11):2567-75. PubMed ID: 17054109
[TBL] [Abstract][Full Text] [Related]
8. Value of intraoperative neck margin analysis during Whipple for pancreatic adenocarcinoma: a multicenter analysis of 1399 patients.
Kooby DA; Lad NL; Squires MH; Maithel SK; Sarmiento JM; Staley CA; Adsay NV; El-Rayes BF; Weber SM; Winslow ER; Cho CS; Zavala KA; Bentrem DJ; Knab M; Ahmad SA; Abbott DE; Sutton JM; Kim HJ; Yeh JJ; Aufforth R; Scoggins CR; Martin RC; Parikh AA; Robinson J; Hashim YM; Fields RC; Hawkins WG; Merchant NB
Ann Surg; 2014 Sep; 260(3):494-501; discussion 501-3. PubMed ID: 25115425
[TBL] [Abstract][Full Text] [Related]
9. Margin status impacts survival after pancreaticoduodenectomy but negative margins should not be pursued.
Mathur A; Ross SB; Luberice K; Kurian T; Vice M; Toomey P; Rosemurgy AS
Am Surg; 2014 Apr; 80(4):353-60. PubMed ID: 24887665
[TBL] [Abstract][Full Text] [Related]
10. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB
Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881
[TBL] [Abstract][Full Text] [Related]
11. Invasive ductal adenocarcinoma of the pancreas may originate from the larger pancreatic duct: a study of 13 tumors less than 2 cm in diameter.
Suda K; Nobukawa B; Yamasaki S; Abe K; Matsukuma S; Suzuki F
J Hepatobiliary Pancreat Surg; 2007; 14(3):283-8. PubMed ID: 17520204
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma in the Netherlands: A Nationwide Retrospective Analysis.
de Rooij T; Tol JA; van Eijck CH; Boerma D; Bonsing BA; Bosscha K; van Dam RM; Dijkgraaf MG; Gerhards MF; van Goor H; van der Harst E; de Hingh IH; Kazemier G; Klaase JM; Molenaar IQ; Patijn GA; van Santvoort HC; Scheepers JJ; van der Schelling GP; Sieders E; Busch OR; Besselink MG;
Ann Surg Oncol; 2016 Feb; 23(2):585-91. PubMed ID: 26508153
[TBL] [Abstract][Full Text] [Related]
13. Data analysis of 36 cases with intraductal papillary mucinous neoplasm of the pancreas for their clinicopathological features, diagnosis, and treatment.
Yuan C; Xiu D; Tao M; Ma Z; Jiang B; Li Z; Li L; Wang L; Wang H; Zhang T
Chin Med J (Engl); 2014; 127(23):4087-91. PubMed ID: 25430454
[TBL] [Abstract][Full Text] [Related]
14. Nonoperative management of main pancreatic duct-involved intraductal papillary mucinous neoplasm might be indicated in select patients.
Roch AM; DeWitt JM; Al-Haddad MA; Schmidt CM; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
J Am Coll Surg; 2014 Jul; 219(1):122-9. PubMed ID: 24862887
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of frozen section analysis during resection of intraductal papillary mucinous neoplasm: should a positive pancreatic margin for adenoma or borderline lesion be resected additionally?
Nara S; Shimada K; Sakamoto Y; Esaki M; Kosuge T; Hiraoka N
J Am Coll Surg; 2009 Nov; 209(5):614-21. PubMed ID: 19854402
[TBL] [Abstract][Full Text] [Related]
16. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas.
Schnelldorfer T; Sarr MG; Nagorney DM; Zhang L; Smyrk TC; Qin R; Chari ST; Farnell MB
Arch Surg; 2008 Jul; 143(7):639-46; discussion 646. PubMed ID: 18645105
[TBL] [Abstract][Full Text] [Related]
17. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
Ridwelski K; Meyer F; Schmidt U; Lippert H
Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
[TBL] [Abstract][Full Text] [Related]
18. [A case report of total remnant pancreatectomy for ductal carcinoma after distal pancreatectomy for invasive intraductal papillary mucinous carcinoma].
Okubo K; Hama N; Kobayashi S; Eguchi H; Akita H; Wada H; Kawamoto K; Marubashi S; Tanemura M; Umeshita K; Mori M; Doki Y; Nagano H
Gan To Kagaku Ryoho; 2012 Nov; 39(12):2140-2. PubMed ID: 23268003
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of adjuvant therapy for pancreatic invasive intraductal papillary mucinous neoplasm (IPMN).
McMillan MT; Lewis RS; Drebin JA; Teitelbaum UR; Lee MK; Roses RE; Fraker DL; Vollmer CM
Cancer; 2016 Feb; 122(4):521-33. PubMed ID: 26587698
[TBL] [Abstract][Full Text] [Related]
20. Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas.
Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
Ann Surg Oncol; 2007 Nov; 14(11):3174-80. PubMed ID: 17694416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
